These data identify a need to systematically establish structure–activity relationships for specific acyl chains, potentially explaining how SF-1 polymorphisms contribute to adrenal insufficiency, ovarian insufficiency, and other disorders of sexual development in human patients. This evidence concerns the gene SF1 and ovarian dysfunction.